Oncostatin M (OM), which shares functional similarity and structural homology to leukemia inhibitory factor (LIF) and interleukin-6 (IL-6), functions as a potent growth factor for AIDS-associated Kaposi's sarcoma-derived cells (AIDS-KS cells). OM was also suggested to bind to the LIF receptor (LIF/OM receptor), which consists of a signal transducing subunit for LIF and IL-6 (gp130) and a LIF receptor alpha-subunit. Recent studies indicate that IL-6 has growth-stimulating activity for AIDS-KS cells. However, we find that AIDS-KS cell growth is exclusively induced by OM and not by LIF or IL-6. We also observed the lack of binding properties of AIDS-KS cells for LIF and IL-6. Scatchard plots revealed the existence of two affinity classes of OM receptor sites on AIDS-KS cells, with Kd values of 6-12 pM (high affinity) and 521-815 pM (low affinity). In competition binding studies, we find that the OM-specific receptor, but not the LIF/OM receptor, contributes to the OM-specific growth stimulation of AIDS-KS cells. We also noted that anti-gp130 antibodies can completely abolish OM-induced growth stimulation of AIDS-KS cells as well as OM binding to AIDS-KS cells. PCR amplification clearly revealed high levels of gp130 expression in AIDS-KS cells, while the transcript of LIF receptor alpha-subunit or IL-6 receptor alpha-subunit was not observed. Therefore, we conclude that (a) AIDS-KS cells express the OM-specific receptor with high and low affinity, but not the LIF/OM receptor; (b) gp130 on AIDS-KS cells plays a key role in OM binding and signaling on the OM-specific receptor; and (c) the lack of biological response of AIDS-KS cells to IL-6 and LIF can be explained by the absence of the IL-6 and LIF/OM receptors. All this evidence shows the correlation of OM-specific biological activity with expression of the OM-specific receptor and the involvement of gp130 on this receptor, as based on findings in in vitro growth assays and binding experiments for AIDS-KS cells.
K Murakami-Mori, T Taga, T Kishimoto, S Nakamura
Title and authors | Publication | Year |
---|---|---|
The clinical relevance of OSM in inflammatory diseases: a comprehensive review
Wolf CL, Pruett C, Lighter D, Jorcyk CL |
Frontiers in immunology | 2023 |
The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights.
Halder S, Parte S, Kshirsagar P, Muniyan S, Nair HB, Batra SK, Seshacharyulu P |
2022 | |
Effect of formaldehyde at a low concentration on proliferation and organization of cytoskeleton of cultured cells
AA Aizenshtadt, EB Burova, VV Zenin, DE Bobkov, IV Kropacheva, GP Pinaev |
Cell and Tissue Biology | 2012 |
Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Inhibits Neutrophil Recruitment through an Interleukin-6-Dependent Mechanism: a New Paradigm for Viral Immune Evasion
LM Butler, HC Jeffery, RL Wheat, PC Rae, K Townsend, KR Alkharsah, TF Schulz, GB Nash, DJ Blackbourn |
Journal of virology | 2011 |
Blocking MAPK Signaling Downregulates CCL21 in Lymphatic Endothelial Cells and Impairs Contact Hypersensitivity Responses
T Miyagaki, M Sugaya, H Okochi, Y Asano, Y Tada, T Kadono, A Blauvelt, K Tamaki, S Sato |
Journal of Investigative Dermatology | 2011 |
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken |
Advances in Cancer Research Volume 110 | 2011 |
Topley & Wilson's Microbiology and Microbial Infections
PM Pitha, MS Künzi |
Topley & Wilson's Microbiology and Microbial Infections | 2010 |
Oncostatin M Enhances CCL21 Expression by Microvascular Endothelial Cells and Increases the Efficiency of Dendritic Cell Trafficking to Lymph Nodes
M Sugaya, L Fang, AR Cardones, T Kakinuma, SH Jaber, A Blauvelt, ST Hwang |
Journal of immunology (Baltimore, Md. : 1950) | 2006 |
Transcriptional responses of human epidermal keratinocytes to Oncostatin-M
N Finelt, A Gazel, S Gorelick, M Blumenberg |
Cytokine | 2005 |
Cross-talk among gp130 Cytokines in Adipocytes
S Zvonic, JE Baugh, P Arbour-Reily, RL Mynatt, JM Stephens |
The Journal of biological chemistry | 2005 |
Therapeutic options for human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus-related disorders
Y Aoki, G Tosato |
Expert Review of Anti-infective Therapy | 2004 |
Pathogenesis and manifestations of human herpesvirus-8-associated disorders
Y Aoki, G Tosato |
Seminars in Hematology | 2003 |
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
M Tanaka, Y Hirabayashi, T Sekiguchi, T Inoue, M Katsuki, A Miyajima |
Blood | 2003 |
The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases
Karl-Josef Kallen |
Biochimica et Biophysica Acta | 2002 |
Structure-Function Relationships of Human Pathogenic Viruses
A Holzenburg, E Bogner |
2002 | |
Exclusive neutrophil recruitment with oncostatin M in a human system
SM Kerfoot, E Raharjo, M Ho, J Kaur, S Serirom, DM McCafferty, AR Burns, KD Patel, P Kubes |
The American Journal of Pathology | 2001 |
Differential effects of oncostatin M and leukaemia inhibitory factor expression in astrocytoma cells
A Kasza, K Rogowski, W Kilarski, R Sobota, T Bernas, J Dobrucki, J Travis, A Koj, M Bugno, T Kordula |
Biochemical Journal | 2001 |
State-of-the-Art Review: Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6
Y Aoki, KD Jones, G Tosato |
Journal of Hematotherapy & Stem Cell Research | 2000 |
Oncostatin M and Transforming Growth Factor-β1 Induce Post-translational Modification and Hyaluronan Binding to CD44 in Lung-derived Epithelial Tumor Cells
J Cichy, E Puré |
The Journal of biological chemistry | 2000 |
p38MAP Kinase Is a Negative Regulator for ERK1/2-Mediated Growth of AIDS-Associated Kaposi's Sarcoma Cells
K Murakami-Mori, S Mori, S Nakamura |
Biochemical and Biophysical Research Communications | 1999 |
The role of HHV-8 in Kaposi's sarcoma
F Neipel, B Fleckenstein |
Seminars in Cancer Biology | 1999 |
HIV and the New Viruses
S McAdam, F Gotch |
HIV and the New Viruses | 1999 |
Advances in Protein Chemistry
CM Silva, J Isgaard, MO Thorner |
Advances in Protein Chemistry | 1998 |
Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex
GE Ringheim, AM Szczepanik, W Petko, KL Burgher, SZ Zhu, CC Chao |
Molecular Brain Research | 1998 |
Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
B Ensoli |
Cytokine & Growth Factor Reviews | 1998 |
Oncostatin M and the Interleukin-6 and Soluble Interleukin-6 Receptor Complex Regulate α 1 -Antichymotrypsin Expression in Human Cortical Astrocytes
T Kordula, RE Rydel, EF Brigham, F Horn, PC Heinrich, J Travis |
The Journal of biological chemistry | 1998 |
Regulation of the gp80 and gp130 subunits of the IL-6 receptor by sex steroids in the murine bone marrow
SC Lin, T Yamate, Y Taguchi, VZ Borba, G Girasole, CA O'Brien, T Bellido, E Abe, SC Manolagas |
Journal of Clinical Investigation | 1997 |
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6
J Nicholas, VR Ruvolo, WH Burns, G Sandford, X Wan, D Ciufo, SB Hendrickson, HG Guo, GS Hayward, MS Reixz |
Nature Medicine | 1997 |
The therapeutic potential of interleukin-6 hyperagonists and antagonists
KJ Kallen, KH Büschenfelde, S Rose-John |
Expert Opinion on Investigational Drugs | 1997 |
Cytokines and the hepatic acute phase response
H Moshage |
The Journal of Pathology | 1997 |
The Signal Transducer gp130 Is Shared by lnterleukin-6 Family of Haematopoietic and Neurotrophic Cytokines
T Taga |
Annals of Medicine | 1997 |
gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
T Taga, T Kishimoto |
Annual Review of Immunology | 1997 |
Human herpesvirus 8 encodes a homolog of interleukin-6
F Neipel, JC Albrecht, A Ensser, YQ Huang, JJ Li, AE Friedman-Kien, B Fleckenstein |
Journal of virology | 1997 |
Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?
F Neipel, JC Albrecht, B Fleckenstein |
Journal of virology | 1997 |
Isolation and Characterization of the Human gp130 Promoter: REGULATION BY STATS
CA OBrien, SC Manolagas |
The Journal of biological chemistry | 1997 |
Interleukin-4 Receptor Expression on AIDS-Associated Kaposi’s Sarcoma Cells and Their Targeting by a Chimeric Protein Comprised of Circularly Permuted Interleukin-4 and Pseudomonas Exotoxin
SR Husain, P Gill, RJ Kreitman, I Pastan, RK Puri |
Molecular Medicine | 1997 |
Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology
ES Wijelath, B Carlsen, T Cole, J Chen, S Kothari, WP Hammond |
Journal of cell science | 1997 |
Dual Oncostatin M (OSM) Receptors: CLONING AND CHARACTERIZATION OF AN ALTERNATIVE SIGNALING SUBUNIT CONFERRING OSM-SPECIFIC RECEPTOR ACTIVATION
B Mosley, CD Imus, D Friend, N Boiani, B Thoma, LS Park, D Cosman |
The Journal of biological chemistry | 1996 |
Contradictory concepts in the etiology and regression of kaposi’s sarcoma: The Ferenc Györkey memorial lecture
JG Sinkovics |
Pathology & Oncology Research | 1996 |
Bone Marrow Transplantation
R Champlin |
Bone Marrow Transplantation | 1990 |